Literature DB >> 19498365

Mesenchymal stem cells: another anti-inflammatory treatment for sepsis?

Guillaume Monneret.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19498365     DOI： 10.1038/nm0609-601

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

Review 1.  Normal responses to injury prevent systemic inflammation and can be immunosuppressive.

Authors:  R S Munford; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

Review 2.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

3.  Mesenchymal stem cells combat sepsis.

Authors:  Alan Tyndall; Vito Pistoia
Journal:  Nat Med       Date:  2009-01       Impact factor: 53.440

4.  Shattuck lecture--clinical research to clinical practice--lost in translation?

Authors:  Claude Lenfant
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

5.  HMG-1 as a late mediator of endotoxin lethality in mice.

Authors:  H Wang; O Bloom; M Zhang; J M Vishnubhakat; M Ombrellino; J Che; A Frazier; H Yang; S Ivanova; L Borovikova; K R Manogue; E Faist; E Abraham; J Andersson; U Andersson; P E Molina; N N Abumrad; A Sama; K J Tracey
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

Review 6.  Immunostimulation is a rational therapeutic strategy in sepsis.

Authors:  Jérôme Pugin
Journal:  Novartis Found Symp       Date:  2007

Review 7.  Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?

Authors:  Alex Dyson; Mervyn Singer
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

8.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

9.  Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients.

Authors:  Fabienne Venet; Chun-Shiang Chung; Hakim Kherouf; Anne Geeraert; Chistophe Malcus; Françoise Poitevin; Julien Bohé; Alain Lepape; Alfred Ayala; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2008-10-23       Impact factor: 17.440

10.  Adverse functions of IL-17A in experimental sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Hongwei Gao; Laszlo M Hoesel; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus S Huber-Lang; James L M Ferrara; Peter A Ward
Journal:  FASEB J       Date:  2008-02-25       Impact factor: 5.834
View more
  1 in total

1.  Murine model: maternal administration of stem cells for prevention of prematurity.

Authors:  Jun Lei; Wance Firdaus; Jason M Rosenzweig; Shorouq Alrebh; Ahmed Bakhshwin; Talaibek Borbiev; Ali Fatemi; Karin Blakemore; Michael V Johnston; Irina Burd
Journal:  Am J Obstet Gynecol       Date:  2014-12-30       Impact factor: 8.661
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.